Stock
Keros Therapeutics Inc’s Shares Reel: 29.22% Quarterly Revenue Decline Amid 2.37B Market Cap
The market performance of Keros Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $73.00 on 02/29/24, while the lowest value for the same duration was $27.31 on 12/12/23. 52-week price history of
